Table 1. Characteristics of patients in COVID-19 with or without cancera.
| Of patients with cancer | ||||
|---|---|---|---|---|
| Characteristics | No cancer (n = 253,179) | Cancer (n = 18,460) | History of cancer (n = 8,034) | Recent cancer (n = 10,426) |
| Age, yr, median [IQR] | 46 [32–60] | 66 (56–76) | 65 [55–77] | 66 [57–76] |
| Age group | ||||
| 18–44 | 119,419 (47.2) | 1,837 (10.0) | 934 (11.6) | 903 (8.7) |
| 45–54 | 45,383 (17.9) | 2,354 (12.8) | 1,071 (13.3) | 1,283 (12.3) |
| 55–64 | 43,791 (17.3) | 4,423 (24.0) | 1,870 (23.3) | 2,553 (24.5) |
| 65–74 | 25,151 (9.9) | 4,556 (24.7) | 1,815 (22.6) | 2,741 (26.3) |
| 75+ | 19,435 (7.7) | 5,290 (28.7) | 2,344 (29.2) | 2,946 (28.3) |
| Male | 108,203 (42.7) | 8,354 (45.3) | 3,424 (42.6) | 4,930 (47.3) |
| Race/Ethnicity | ||||
| White | 180,960 (71.5) | 14,748 (79.9) | 6,517 (81.1) | 8,231 (78.9) |
| Black | 25,644 (10.1) | 1,719 (9.3) | 696 (8.7) | 1,023 (9.8) |
| Hispanic | 26,262 (10.4) | 1,221 (6.6) | 470 (5.9) | 751 (7.2) |
| Other/unknown | 20,313 (8.0) | 772 (4.2) | 351 (4.4) | 421 (4.0) |
| Insurance | ||||
| Commercial | 165,986 (65.6) | 9,926 (53.8) | 4,404 (54.8) | 5,522 (53.0) |
| Medicare | 27,748 (11.0) | 6,066 (32.9) | 2,478 (30.8) | 3,588 (34.4) |
| Medicaid | 20,645 (8.2) | 875 (4.7) | 353 (4.4) | 522 (5.0) |
| Uninsured | 8,442 (3.3) | 273 (1.5) | 124 (1.5) | 149 (1.4) |
| Other | 12,078 (4.8) | 662 (3.6) | 294 (3.7) | 368 (3.5) |
| Unknown | 18,280 (7.2) | 658 (3.6) | 381 (4.7) | 277 (2.7) |
| Region | ||||
| Northeast | 36,021 (14.2) | 3,407 (18.5) | 1,465 (18.2) | 1,942 (18.6) |
| Midwest | 147,304 (58.2) | 10,001 (54.2) | 4,280 (53.3) | 5,721 (54.9) |
| South | 45,318 (17.9) | 3,553 (19.2) | 1,644 (20.5) | 1,909 (18.3) |
| West | 15,867 (6.3) | 1,099 (6.0) | 462 (5.8) | 637 (6.1) |
| Other/Unknown | 8,669 (3.4) | 400 (2.2) | 183 (2.3) | 217 (2.1) |
| Risk Factors | ||||
| Chronic Pulmonary Disease | 62,429 (24.7) | 7,665 (41.5) | 3,263 (40.6) | 4,402 (42.2) |
| Cardiovascular Disease | 49,725 (19.6) | 8,883 (48.1) | 3,700 (46.1) | 5,183 (49.7) |
| Cerebrovascular Disease | 15,599 (6.2) | 3,475 (18.8) | 1,489 (18.5) | 1,986 (19.0) |
| Peripheral Vascular Disease | 14,708 (5.8) | 4,210 (22.8) | 1,636 (20.4) | 2,574 (24.7) |
| Diabetes | 42,542 (16.8) | 6,267 (33.9) | 2,619 (32.6) | 3,648 (35.0) |
| Obesity | 80,978 (32.0) | 8,383 (45.4) | 3,596 (44.8) | 4,787 (45.9) |
| Liver Disease | 18,270 (7.2) | 3,716 (20.1) | 1,378 (17.2) | 2,338 (22.4) |
| Renal Disease | 18,145 (7.2) | 4,518 (24.5) | 1,843 (22.9) | 2,675 (25.7) |
| COVID-19 Outcomes | ||||
| Death 30 days | 4,854 (1.9) | 1,258 (6.8) | 477 (5.9) | 781 (7.5) |
| Inpatient | 25,092 (9.9) | 4,060 (22.0) | 1,584 (19.7) | 2,476 (23.7) |
| ICU | 6,449 (2.5) | 1,101 (6.0) | 427 (5.3) | 674 (6.5) |
| Ventilator | 2,855 (1.1) | 510 (2.8) | 178 (2.2) | 332 (3.2) |
Abbreviations: IQR, interquartile range; ICU, intensive care unit.
aData are presented as number (percentage) of patients unless otherwise indicated. All p values for differences in characteristics between non-cancer and cancer groups are <0.001.